Telehealth laws are applicable where the patient is located, so if a doctor in one state prescribes a peptide that is not allowed in another state where the patient is located, it would be against the medical board of the state where the patient is 2m6s
GHK-Cu is the copper complex of Gly-His-Lys
Reported Side Effects Epithalon is generally well-tolerated, with most users reporting minimal to no side effects
BPC-157 may not be appropriate when: Imaging or specialist review has not yet been completed for a suspected structural injury There are acute red flag features (severe weakness, fever, rapid unexplained swelling, neurological changes, unexplained weight loss) The patient has active cancer or a history of certain cancers where angiogenic peptides require careful risk assessment The goal is rapid results without addressing underlying load, rehabilitation, or lifestyle drivers A peptide should not be used to delay evaluation that is clearly warranted
No mutagenicity, carcinogenicity, or reproductive toxicity has been demonstrated
